Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1Pancreatic Diseases 1Gallbladder Diseases 1Choledocholithiasis 1Biliary Tract Neoplasms 1

Interventions

Gemcitabine 94Cisplatin 71Capecitabine 39Oxaliplatin 38durvalumab 29Fluorouracil 27pembrolizumab 26Leucovorin 23S 1 (combination) 19Nivolumab 14Irinotecan 14lenvatinib 13Bevacizumab 11tremelimumab 10130-nm albumin-bound paclitaxel 9apatinib 8Trastuzumab 7Injections 7Immune Checkpoint Inhibitors 7Docetaxel 7Albumin-Bound Paclitaxel 7Paclitaxel 6Drug Therapy 6titanium silicide 5surufatinib 5irinotecan sucrosofate 5gemcitabine-oxaliplatin regimen 5envafolimab 5camrelizumab 5atezolizumab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Biliary Tract Neoplasms × Duodenoscopes × Clear all
NCT05429203 2025-09-15

Comparison of Duodenoscope With Single-use Distal Cover and the Conventional Reusable Duodenoscope

Stanford University

Phase NA Completed
319 enrolled 21 charts
Gastrointestinal

Biliary Tract Neoplasms, Gallbladder Diseases, Pancreatic Diseases, Pancreatic Neoplasms, Choledocholithiasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡